DD256703A5 - Verfahren zur herstellung von 16,17-acetal-substituierten pregnan-21-saeurederivaten - Google Patents

Verfahren zur herstellung von 16,17-acetal-substituierten pregnan-21-saeurederivaten Download PDF

Info

Publication number
DD256703A5
DD256703A5 DD86297902A DD29790286A DD256703A5 DD 256703 A5 DD256703 A5 DD 256703A5 DD 86297902 A DD86297902 A DD 86297902A DD 29790286 A DD29790286 A DD 29790286A DD 256703 A5 DD256703 A5 DD 256703A5
Authority
DD
German Democratic Republic
Prior art keywords
acid
formula
butylidenedioxy
difluoro
hydroxy
Prior art date
Application number
DD86297902A
Other languages
German (de)
English (en)
Inventor
Paul H Andersson
Per T Andersson
Bengt I Axelsson
Ralph L Brattsand
Bror A Thalen
Jan W Trofast
Original Assignee
������@������������k��
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ������@������������k�� filed Critical ������@������������k��
Publication of DD256703A5 publication Critical patent/DD256703A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • C07J71/0026—Oxygen-containing hetero ring cyclic ketals
    • C07J71/0031—Oxygen-containing hetero ring cyclic ketals at positions 16, 17
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DD86297902A 1985-12-19 1986-12-18 Verfahren zur herstellung von 16,17-acetal-substituierten pregnan-21-saeurederivaten DD256703A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8506015A SE8506015D0 (sv) 1985-12-19 1985-12-19 Novel 16,17-acetalsubstituted pregnane 21-oic acid derivatives

Publications (1)

Publication Number Publication Date
DD256703A5 true DD256703A5 (de) 1988-05-18

Family

ID=20362521

Family Applications (1)

Application Number Title Priority Date Filing Date
DD86297902A DD256703A5 (de) 1985-12-19 1986-12-18 Verfahren zur herstellung von 16,17-acetal-substituierten pregnan-21-saeurederivaten

Country Status (31)

Country Link
EP (1) EP0232690B1 (xx)
JP (1) JPH0780900B2 (xx)
KR (1) KR940004067B1 (xx)
CN (1) CN1016508B (xx)
AR (1) AR242797A1 (xx)
AT (1) ATE57935T1 (xx)
AU (1) AU591950B2 (xx)
CA (1) CA1318664C (xx)
CS (1) CS266597B2 (xx)
DD (1) DD256703A5 (xx)
DE (1) DE3675378D1 (xx)
DK (1) DK168601B1 (xx)
ES (1) ES2018656B3 (xx)
FI (1) FI84488C (xx)
GR (1) GR3001052T3 (xx)
HU (1) HU196831B (xx)
IE (1) IE59241B1 (xx)
IL (1) IL80679A (xx)
IS (1) IS1559B (xx)
JO (1) JO1499B1 (xx)
LT (1) LT3912B (xx)
LV (1) LV10959B (xx)
MY (1) MY100750A (xx)
NO (1) NO164243C (xx)
NZ (1) NZ218614A (xx)
PH (1) PH23237A (xx)
PL (1) PL151627B1 (xx)
PT (1) PT83984B (xx)
RU (1) RU1839673C (xx)
SE (1) SE8506015D0 (xx)
ZA (1) ZA868750B (xx)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU203769B (en) * 1989-03-09 1991-09-30 Richter Gedeon Vegyeszet Process for producing new steroide derivatives and pharmaceutical compositions containing them
US5643602A (en) * 1989-11-22 1997-07-01 Astra Aktiebolag Oral composition for the treatment of inflammatory bowel disease
SE8903914D0 (sv) 1989-11-22 1989-11-22 Draco Ab Oral composition for the treatment of inflammatory bowel diseases
US6166024A (en) 1995-03-30 2000-12-26 Mayo Foundation For Medical Education And Research Use of topical azathioprine and thioguanine to treat colorectal adenomas
CA3018328A1 (en) 2014-10-31 2016-04-30 Purdue Pharma Methods and compositions particularly for treatment of attention deficit disorder
US10722473B2 (en) 2018-11-19 2020-07-28 Purdue Pharma L.P. Methods and compositions particularly for treatment of attention deficit disorder

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2150268C3 (de) * 1971-10-04 1980-11-06 Schering Ag, 1000 Berlin Und 4619 Bergkamen Pregnansäure-Derivate, Verfahren zu ihrer Herstellung sowie diese enthaltende Arzneimittel
DE2204360C2 (de) * 1972-01-27 1982-11-04 Schering Ag, 1000 Berlin Und 4619 Bergkamen Neue Pregnansäure-Derivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Präparate
DD95565B1 (de) * 1971-10-04 1986-10-29 Schering Ag Verfahren zur herstellung neuer pregnansaeurederivate
SE378109B (xx) * 1972-05-19 1975-08-18 Bofors Ab
IE38659B1 (en) * 1972-12-22 1978-05-10 Schering Ag New pregnane acid derivatives
DE2264003C2 (de) * 1972-12-22 1982-11-04 Schering Ag, 1000 Berlin Und 4619 Bergkamen Neue Pregnansäure-Derivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Präparate
SE8403905D0 (sv) * 1984-07-30 1984-07-30 Draco Ab Liposomes and steroid esters

Also Published As

Publication number Publication date
NZ218614A (en) 1989-02-24
ZA868750B (en) 1987-08-26
EP0232690B1 (en) 1990-10-31
SE8506015D0 (sv) 1985-12-19
MY100750A (en) 1991-02-14
LT3912B (en) 1996-04-25
JPS62155296A (ja) 1987-07-10
DK605186D0 (da) 1986-12-16
CS960486A2 (en) 1989-04-14
CS266597B2 (en) 1990-01-12
HU196831B (en) 1989-01-30
HUT44273A (en) 1988-02-29
PL151627B1 (en) 1990-09-28
FI865128A (fi) 1987-06-20
IS3179A7 (is) 1987-06-20
RU1839673C (ru) 1993-12-30
CN86108634A (zh) 1987-07-22
DK168601B1 (da) 1994-05-02
LV10959B (en) 1996-06-20
IE59241B1 (en) 1994-01-26
PL263041A1 (en) 1988-07-21
AU6644886A (en) 1987-06-25
IL80679A0 (en) 1987-02-27
FI84488C (fi) 1991-12-10
LV10959A (lv) 1995-12-20
ES2018656B3 (es) 1991-05-01
KR870006081A (ko) 1987-07-09
NO865004L (no) 1987-06-22
NO865004D0 (no) 1986-12-11
NO164243B (no) 1990-06-05
PH23237A (en) 1989-06-06
IL80679A (en) 1992-03-29
IS1559B (is) 1994-10-05
AR242797A1 (es) 1993-05-31
EP0232690A1 (en) 1987-08-19
GR3001052T3 (en) 1992-03-20
PT83984A (en) 1987-01-01
ATE57935T1 (de) 1990-11-15
FI84488B (fi) 1991-08-30
JPH0780900B2 (ja) 1995-08-30
NO164243C (no) 1990-09-19
CN1016508B (zh) 1992-05-06
DK605186A (da) 1987-06-20
FI865128A0 (fi) 1986-12-16
PT83984B (pt) 1989-07-31
AU591950B2 (en) 1989-12-21
CA1318664C (en) 1993-06-01
IE863245L (en) 1987-06-19
JO1499B1 (en) 1988-03-10
DE3675378D1 (de) 1990-12-06
KR940004067B1 (ko) 1994-05-11
LTIP1682A (en) 1995-07-25

Similar Documents

Publication Publication Date Title
DE2707336C2 (xx)
DE2323215C3 (de) Pregna-l,4-dien-ll-ol-3,20-dione, Verfahren zu deren Herstellung und sie enthaltende Arzneimittel
DE4129535C2 (de) Pregna-1,4-dien-3,20-dion-16-17-acetal-21-ester, Verfahren zur Herstellung, sowie diese enthaltende pharmazeutische Präparate
DD248055A5 (de) Verfahren zur herstellung eines pharmazeutischen praeparates
EP0135476B1 (de) Steroid Carbonsäureester
DE2817988A1 (de) Corticoid 17-alkylcarbonate und verfahren zu deren herstellung
CH619968A5 (xx)
DE2162595A1 (de) Steroide der Androstanreihe und Verfahren zu ihrer Herstellung
DE1618065C3 (de) 21-Oxo-23-desoxo-cardenoIide, Verfahren zu deren Herstellung und daraus hergestellte Arzneimittel
DD256703A5 (de) Verfahren zur herstellung von 16,17-acetal-substituierten pregnan-21-saeurederivaten
DE2755547C2 (xx)
DE2047105C3 (de) 17-Chlorsteroide und Verfahren zu ihrer Herstellung
DE3336292C2 (xx)
DD95565B1 (de) Verfahren zur herstellung neuer pregnansaeurederivate
DE2852055C2 (xx)
DE2365992C3 (de) 6α-Fluor-17,21-dihydroxy-16β-methylpregna-4,9(11)-dien-3,20-dion-17,21-diacetat und Verfahren zu dessen Herstellung
EP0077541B1 (de) Delta-1,3,5-3-Chlor-11-Beta,16-Alpha,17-Alpha,21-tetra-(hydroxy)-pregnan-20-on-16,17-acetonidderivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE2614079C2 (de) D-Homosteroide, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Präparate
DE2162594A1 (de) 3 alpha-oxygenierte Pregnan-21-äther und Verfahren zu deren Herstellung
US5215979A (en) 16,17-acetalsubstituted pregnane 21-oic acid derivatives
DE1807585C3 (de) 14,15beta-Epoxycardenolide, Verfahren zu deren Herstellung und diese enthaltende Mittel
CH616691A5 (en) Process for the preparation of steroid compounds and their use.
AT253135B (de) Verfahren zur Herstellung neuer Steroidverbindungen
DE2543521C3 (de) Carboxyandrostan-l,4-dien-17 ß- hydroxy-3-one, Verfahren zu ihrer Herstellung und diese enthaltende Heilmittel
DE1618917C3 (de) 6 alpha, 21-Difluorsteroide sowie Verfahren zu deren Herstellung

Legal Events

Date Code Title Description
IF04 In force in the year 2004

Expiry date: 20061219